# Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD)

> **NCT01377285** · PHASE4 · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 350 (estimated)

## Conditions studied

- Chronic Renal Failure

## Interventions

- **DRUG:** ARB
- **DRUG:** Pentoxifylline
- **DRUG:** Placebo (for Pentoxifylline)

## Key facts

- **NCT ID:** NCT01377285
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-06
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2016-10-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01377285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01377285, "Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01377285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*